| 2005 |
Keller H, Kneissel M. SOST is a target gene for PTH in bone. Bone. August 2005;37(2):148-158. |
52 |
49 |
| 2020 |
Albiol L, Büttner A, Pflanz D, Mikolajewicz N, Birkhold AI, Kramer I, Kneissel M, Duda GN, Checa S, Willie BM. Effects of long-term sclerostin deficiency on trabecular bone mass and adaption to limb loading differ in male and female mice. Calcif Tiss Int. April 2020;106(4):415-430. |
1 |
1 |
| 2010 |
Kramer I, Loots GG, Studer A, Keller H, Kneissel M. Parathyroid hormone (PTH)–induced bone gain is blunted in SOST overexpressing and deficient mice. J Bone Miner Res. February 2010;25(2):178-189. |
21 |
17 |
| 2001 |
Roschger P, Grabner BM, Rinnerthaler S, Tesch W, Kneissel M, Berzlanovich A, Klaushofer K, Fratzl P. Structural development of the mineralized tissue in the human L4 vertebral body. J Struct Biol. November 2001;136(2):126-136. |
24 |
16 |
| 2010 |
Kramer I, Halleux C, Keller H, Pegurri M, Gooi JH, Weber PB, Feng JQ, Bonewald LF, Kneissel M. Osteocyte Wnt/β-catenin signaling is required for normal bone homeostasis. Mol Cell Biol. June 15, 2010;30(12):3071-3085. |
34 |
30 |
| 2013 |
Baron R, Kneissel M. WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med. February 2013;19(2):179-192. |
75 |
75 |